NIH/NIA: Multimorbidity in Alzheimer’s disease impacts choice of ancillary treatments

This aims to improve the effectiveness of treatment strategies for comorbid conditions that occur frequently in combination with Alzheimer’s disease and related dementia.

For the R21 phase, application budgets are worth up to USD 275,000 for the two year period with no more than USD 200,000 allowed in any single year.

Application budgets are not limited for the R33 five-year phase but need to reflect the actual needs of the proposed project.

Maximum award: Not known

Closing date: 12 Jan 17

For further information see: